EXPLORE!

What are the MCI guidelines for doctors in their relationship with pharma industry?

  999 Views

eMediNexus    15 February 2022

The MCI, through an amendment to the “Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulation 2002”, introduced a code of conduct for doctors and professional associations of doctors in their relationship with pharmaceutical and allied health sector industry which prohibits them from accepting any gifts, travel facility or hospitality, from any pharmaceutical company or the health care industry. These Regulations are called the “Indian Medical Council (Professional Conduct, Etiquette and Ethics) (Amendment) Regulations, 2009 - Part-I”.

“6.8 Code of conduct for doctors and professional association of doctors in their relationship with pharmaceutical and allied health sector industry.

6.8.1 In dealing with pharmaceutical and allied health sector industry, a medical practitioner shall follow and adhere to the stipulations given below:

  1. Gifts: A medical practitioner shall not receive any gift from any pharmaceutical or allied health care industry and their sales people or representatives.
  2. Travel facilities: A medical practitioner shall not accept any travel facility inside the country or outside, including rail, air, ship, cruise tickets, paid vacations, etc. from any pharmaceutical or allied health care industry or their representatives for self and family members for vacation or for attending conferences, seminars, workshops, CME programme, etc. as a delegate.
  3. Hospitality: A medical practitioner shall not accept individually any hospitality like hotel accommodation for self and family members under any pretext.
  4. Cash or monetary grants: A medical practitioner shall not receive any cash or monetary grants from any pharmaceutical and allied health care industry for individual purpose in individual capacity under any pretext. Funding for medical research, study, etc. can only be received through approved institutions by modalities laid down by law/rules/guidelines adopted by such approved institutions, in a transparent manner. It shall always be fully disclosed.
  5. Maintaining Professional Autonomy: In dealing  with  pharmaceutical  and  allied  health  care industry a medical practitioner shall always ensure that there shall never be any compromise either with his/her own professional autonomy and/or with the autonomy and freedom of the medical institution.
  6. Affiliation: A medical practitioner may work for pharmaceutical and allied health care industries in advisory capacities, as consultants, as researchers, as treating doctors or in any other professional capacity. In doing so, a medical practitioner shall always:
  1. Ensure that his professional integrity and freedom are maintained
  2. Ensure that patient’s interest are not compromised in any way
  3. Ensure that such affiliations are within the law
  4. Ensure that such affiliations/employments are fully transparent and disclosed.”

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.